Daniel George Wildman's most recent trade in UroGen Pharma Ltd was a trade of 10,000 Stock Option (right ot buy) done . Disclosure was reported to the exchange on Aug. 26, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| UroGen Pharma Ltd | Daniel George Wildman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2025 | 10,000 | 10,000 | - | - | Stock Option (right ot buy) | |
| UroGen Pharma Ltd | Daniel George Wildman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2025 | 8,000 | 8,000 | - | - | Restricted Stock Unit | |
| UroGen Pharma Ltd | Daniel George Wildman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2024 | 10,000 | 10,000 | - | - | Stock Option (right ot buy) | |
| UroGen Pharma Ltd | Daniel George Wildman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) |